InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: mopar44o post# 34730

Sunday, 05/06/2018 11:59:47 AM

Sunday, May 06, 2018 11:59:47 AM

Post# of 38634
I will sum up what they are trying to accomplish this year if anyone is unclear:

1. PODRAS first human results announced mid 2018.
2. Topline HAP studies results second half of 2018.
3. Goal of a Regabatin partner mid 2018.
4. Working on international markets that are available with only FDA approvals(current ANDAs that are approved or will be approved). These are lower volume, higher margin markets. Packaging tests/shelf life tests are in process for these as these markets require different packaging. Late 2018 hopefully for this to start to take off.